Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 69 Prostatic Neoplasms 47 Breast Neoplasms 14 Sarcoma 10 Neoplasms 10 Endometrial Neoplasms 9 Vaginal Neoplasms 7 Esophageal Neoplasms 6 Uterine Neoplasms 4 Radiation Injuries 4 Lung Neoplasms 4 Liver Neoplasms 4 Glioblastoma 4 Carcinoma, Ductal, Breast 4 Adenocarcinoma 4 Vulvar Neoplasms 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Hyperthermia 3 Gliosarcoma 3 Desmoplastic Small Round Cell Tumor 3 Central Nervous System Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Carcinoma In Situ 3 Brain Neoplasms 3 Uveal Melanoma 2 Rhabdomyosarcoma 2 Retinoblastoma 2 Rectal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Pancreatic Neoplasms 2

Interventions

Cyclophosphamide 151 Dexamethasone 140 Rituximab 83 fludarabine 78 Cytarabine 69 Lenalidomide 68 Bortezomib 63 fludarabine phosphate 62 Gemcitabine 62 venetoclax 54 Etoposide 53 pembrolizumab 52 pomalidomide 48 Paclitaxel 48 Cisplatin 47 Carboplatin 47 Peripheral Blood Stem Cell Transplantation 46 Filgrastim 40 Radiotherapy 39 Calcium Dobesilate 36 Busulfan 36 Methotrexate 34 Melphalan 34 Bevacizumab 33 carfilzomib 32 Cyclosporine 32 Azacitidine 32 Mycophenolic Acid 29 Vincristine 28 Temozolomide 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Recurrence × Brachytherapy × Clear all

NCT05715502 2025-04-30

FocaSaBra

The Greater Poland Cancer Centre

Phase NA Recruiting

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡